Relationships between chemical characteristics and anticomplementary activity of fucans

被引:53
作者
Blondin, C
Chaubet, F
Nardella, A
Sinquin, C
Jozefonvicz, J
机构
[1] UNIV PARIS 13, LAB RECH MACROMOL,CNRS,URA 502,IFREMER URM2, INST GALILEE, F-93430 VILLETANEUSE, FRANCE
[2] IFREMER, F-44037 NANTES 01, FRANCE
关键词
fucans; sulphated polysaccharides; heparin-like; complement;
D O I
10.1016/0142-9612(96)88710-2
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
We have shown previously that a low-molecular-weight fucan extracted from the brown seaweed Ascophyllum nodosum strongly inhibited human complement activation in vitro and its mechanism of action was largely elucidated. We further investigated the influence of molecular weight and chemical composition of fucan on its anticomplementary activity. The capacity of 12 fragments of fucan (ranging from a molecular weight of 4100 to 214 000) to prevent complement-mediated haemolysis of sheep erythrocytes (classical pathway) and of rabbit erythrocytes (alternative pathway) increased with increasing molecular weight, and reached a plateau for 40 000 and 13 500, respectively. The most potent fucan fractions were 40-fold more active than heparin in inhibiting the classical pathway. They were, however, as active as heparin in inhibiting the alternative pathway. In addition, we have developed a haemolytic test based on the CH50 protocol, which allows discrimination between activators and inhibitors of complement proteins. Although the mannose content within the different fucan fragments did not vary, the galactose and glucuronic acid contents increased with increasing activity, suggesting that these residues should be essential for full anticomplementary activity. Meanwhile, sulphate groups appeared to be necessary, but were clearly not a sufficient requirement for anticomplementary activity of fucans. Taken together, these data illustrate the prospects for the use of fucans as potential anti-inflammatory agents.
引用
收藏
页码:597 / 603
页数:7
相关论文
共 38 条
[1]  
ASGHAR SS, 1984, PHARMACOL REV, V36, P223
[2]  
BAKER PJ, 1975, J IMMUNOL, V114, P554
[3]   INHIBITION OF COMPLEMENT ACTIVATION BY NATURAL SULFATED POLYSACCHARIDES (FUCANS) FROM BROWN SEAWEED [J].
BLONDIN, C ;
FISCHER, E ;
BOISSONVIDAL, C ;
KAZATCHKINE, MD ;
JOZEFONVICZ, J .
MOLECULAR IMMUNOLOGY, 1994, 31 (04) :247-253
[4]   THE ABILITY OF SEPHADEX TO ACTIVATE HUMAN-COMPLEMENT IS SUPPRESSED IN SPECIFICALLY SUBSTITUTED FUNCTIONAL SEPHADEX DERIVATIVES [J].
CARRENO, MP ;
LABARRE, D ;
JOZEFOWICZ, M ;
KAZATCHKINE, MD .
MOLECULAR IMMUNOLOGY, 1988, 25 (02) :165-171
[5]  
CHEUNG AK, 1992, J AM SOC NEPHROL, V2, P1328
[6]   ADSORPTION OF UNACTIVATED COMPLEMENT PROTEINS BY HEMODIALYSIS MEMBRANES [J].
CHEUNG, AK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1989, 14 (06) :472-477
[7]  
CHONN A, 1991, J IMMUNOL, V146, P4234
[8]  
CHURCH FC, 1989, J BIOL CHEM, V264, P3618
[9]   CORRELATION OF SULFATE CONTENT AND DEGREE OF CARBOXYLATION OF HEPARIN AND RELATED GLYCOSAMINOGLYCANS WITH ANTICOMPLEMENT ACTIVITY - RELATIONSHIPS TO THE ANTI-COAGULANT AND PLATELET-AGGREGATING ACTIVITIES [J].
COFRANCESCO, E ;
RADAELLI, F ;
POGLIANI, E ;
AMICI, N ;
TORRI, GG ;
CASU, B .
THROMBOSIS RESEARCH, 1979, 14 (01) :179-187
[10]   ANTICOAGULANT PROPERTIES OF A FUCOIDAN FRACTION [J].
COLLIEC, S ;
FISCHER, AM ;
TAPONBRETAUDIERE, J ;
BOISSON, C ;
DURAND, P ;
JOZEFONVICZ, J .
THROMBOSIS RESEARCH, 1991, 64 (02) :143-154